<DOC>
	<DOC>NCT02096159</DOC>
	<brief_summary>The primary purpose of this study is to determine if routine use of prophylactic (preventive) antibiotics after repair of mid-to-distal hypospadias is beneficial.</brief_summary>
	<brief_title>Prophylactic Antibiotics or Placebo After Hypospadias Repair</brief_title>
	<detailed_description>Participants in this multicenter, double-blind study are randomized to receive trimethoprim-sulfamethoxazole or placebo for 10 days postoperatively. Short- and intermediate-term results will be published after participants complete 6 months and 5 years of follow-up, respectively.</detailed_description>
	<mesh_term>Hypospadias</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Trimethoprim, Sulfamethoxazole Drug Combination</mesh_term>
	<mesh_term>Sulfamethoxazole</mesh_term>
	<mesh_term>Trimethoprim</mesh_term>
	<criteria>midtodistal shaft hypospadias singlestage hypospadias repair length of urethral repair (urethroplasty) less than or equal to 20 mm placement of an opendrainage urethral stent at the time of hypospadias repair, with intended duration of stenting for 510 days postoperatively previous hypospadias repair prior adverse/allergic reaction or other contraindication to trimethoprimsulfamethoxazole crossreactivity of an existing medication with trimethoprimsulfamethoxazole any patient condition with elevated risk of infection or adverse outcome from potential infection (e.g., HIV/AIDS, poorly controlled diabetes mellitus or other immunocompromising conditions, congenital heart disease) use of antibiotics within seven days prior to hypospadias repair foreskin reconstruction at the time of hypospadias repair prescription of oral antibiotics other than Study Medication at the time of hypospadias repair</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Hypospadias</keyword>
	<keyword>Anti-Bacterial Agents</keyword>
</DOC>